Identification and assessment of new biomarkers for colorectal cancer with serum N-glycan profiling.


Abstract

The current results indicated that the N-glycan markers based diagnostic models are new, valuable, noninvasive alternatives for identifying CRC. The authors concluded that decreased fucosyltransferase may be responsible for decreased levels of total core-fucosylated modification in both tissues and serum from patients with CRC.


Full Text


Subjects


Similar articles

Español | English

© Galenicom 1999-2013